This study proposes a model-based approach utilizing a hybrid population balance model (PBM) to optimize temperature profiles for minimizing agglomeration and enhancing crystal growth. The PBM incorporates key mechanisms—nucleation, growth, dissolution, agglomeration, and deagglomeration—and is ap-plied to the crystallization of an industrial active pharmaceutical ingredient (API), Compound K. Parameters were estimated through prior design of experiments (DoE) and refined via additional thermocycle experiments. In-silico DoE simulations demonstrate that the hybrid PBM outperforms traditional methods in assessing process performance under agglomeration-prone conditions. Results confirm that thermocycles effectively reduce agglomeration and promote bulk crystal formation, though their efficiency plateaus be-yond a certain cycle number. This model-based approach provides a more robust strategy for agglomeration control compared to conventional methods, offering valuable insights for industrial crystallization optimization.